共有 1 页
品牌 | 货号 | 包装单位 | 货期 | 产品名称 | 质量规格 | 单价(¥) | 购买数量 |
---|---|---|---|---|---|---|---|
罗恩 | R031394-25mg | 25mg | 5~7个工作日 |
2-甲基-2-[4-[3-甲基-2-氧代-8-(喹啉-3... 2-methyl-2-[4-(3-methyl-2-ox... |
99% |
|
|
罗恩 | R031394-100mg | 100mg | 5~7个工作日 |
2-甲基-2-[4-[3-甲基-2-氧代-8-(喹啉-3... 2-methyl-2-[4-(3-methyl-2-ox... |
99% |
|
|
阿拉丁 | B126286-25mg | 25mg | 现货 |
BEZ235,有效的PI3K和mTOR抑制剂 BEZ235 |
Moligand™, ≥99% |
|
|
阿拉丁 | B126286-100mg | 100mg | 现货 |
BEZ235,有效的PI3K和mTOR抑制剂 BEZ235 |
Moligand™, ≥99% |
|
|
阿拉丁 | B126286-1g | 1g | 期货,请咨询 |
BEZ235,有效的PI3K和mTOR抑制剂 BEZ235 |
Moligand™, ≥99% |
|
|
阿拉丁 | B126286-250mg | 250mg | 期货,请咨询 |
BEZ235,有效的PI3K和mTOR抑制剂 BEZ235 |
Moligand™, ≥99% |
|
|
凯为 | JZ00GSV2-10mg | 10mg | 期货,请咨询 |
2-甲基-2-(4-(3-甲基-2-氧亚基-8-(喹啉-... BEZ235 (NVP-BEZ235, Dactolis... |
98+% |
|
|
凯为 | JZ00GSV2-50mg | 50mg | 期货,请咨询 |
2-甲基-2-(4-(3-甲基-2-氧亚基-8-(喹啉-... BEZ235 (NVP-BEZ235, Dactolis... |
98+% |
|
|
凯为 | JZ00GSV2-100mg | 100mg | 期货,请咨询 |
2-甲基-2-(4-(3-甲基-2-氧亚基-8-(喹啉-... BEZ235 (NVP-BEZ235, Dactolis... |
98+% |
|
|
毕得 | BD157891-50mg | 50mg | 现货 |
2-甲基-2-(4-(3-甲基-2-氧代-8-(喹啉-3... 2-Methyl-2-(4-(3-methyl-2-ox... |
98+% |
|
|
毕得 | BD157891-100mg | 100mg | 现货 |
2-甲基-2-(4-(3-甲基-2-氧代-8-(喹啉-3... 2-Methyl-2-(4-(3-methyl-2-ox... |
98+% |
|
|
毕得 | BD157891-10mg | 10mg | 现货 |
2-甲基-2-(4-(3-甲基-2-氧代-8-(喹啉-3... 2-Methyl-2-(4-(3-methyl-2-ox... |
98+% |
|
|
Matrix | MA090884-250mg | 250mg | 3-4周 |
2-Methyl-2-(4-(3-methyl-2-ox... 2-Methyl-2-(4-(3-methyl-2-ox... |
95+% | 咨询 | 请联系客服购买! |
安耐吉 | D041104-100mg | 100mg | 期货,请咨询 |
2-甲基-2-(4-(3-甲基-2-氧代-8-(喹啉-3... 2-methyl-2-(4-(3-methyl-2-ox... |
97% |
|
|
安耐吉 | D041104-1g | 1g | 期货,请咨询 |
2-甲基-2-(4-(3-甲基-2-氧代-8-(喹啉-3... 2-methyl-2-(4-(3-methyl-2-ox... |
97% |
|
|
安耐吉 | D041104-250mg | 250mg | 期货,请咨询 |
2-甲基-2-(4-(3-甲基-2-氧代-8-(喹啉-3... 2-methyl-2-(4-(3-methyl-2-ox... |
97% |
|
|
源叶 | S51784-25mg | 25mg | 现货 | Dactolisib(BEZ235) | ≥98% |
|
|
源叶 | S51784-100mg | 100mg | 现货 | Dactolisib(BEZ235) | ≥98% |
|
|
源叶 | S51784-1g | 1g | 期货,请咨询 | Dactolisib(BEZ235) | ≥98% |
|
|
Target Mol | T2235-50mg | 50mg | 现货 |
化合物 Dactolisib Dactolisi |
99.85% |
|
|
Target Mol | T2235-100mg | 100mg | 现货 |
化合物 Dactolisib Dactolisi |
99.85% |
|
|
Target Mol | T2235-200mg | 200mg | 现货 |
化合物 Dactolisib Dactolisi |
99.85% |
|
|
Target Mol | T2235-10mg | 10mg | 现货 |
化合物 Dactolisib Dactolisi |
99.85% |
|
|
Target Mol | T2235-500mg | 500mg | 现货 |
化合物 Dactolisib Dactolisi |
99.85% |
|
|
Am | A224243-5mg | 5mg | 现货 |
Dactolisib Dactolisi |
98+% |
|
|
Am | A224243-1g | 1g | 现货 |
Dactolisib Dactolisi |
98+% |
|
|
Am | A224243-1mg | 1mg | 现货 |
Dactolisib Dactolisi |
98+% |
|
|
Am | A224243-10mg | 10mg | 现货 |
Dactolisib Dactolisi |
98+% |
|
|
Am | A224243-100mg | 100mg | 现货 |
Dactolisib Dactolisi |
98+% |
|
|
Am | A224243-50mg | 50mg | 现货 |
Dactolisib Dactolisi |
98+% |
|
|
Am | A224243-250mg | 250mg | 现货 |
Dactolisib Dactolisi |
98+% |
|
|
MCE | HY-50673-500mg | 500mg | 现货 |
Dactolisib Dactolisi |
99.94% |
|
|
MCE | HY-50673-200mg | 200mg | 现货 |
Dactolisib Dactolisi |
99.94% |
|
|
MCE | HY-50673-100mg | 100mg | 现货 |
Dactolisib Dactolisi |
99.94% |
|
|
MCE | HY-50673-50mg | 50mg | 现货 |
Dactolisib Dactolisi |
99.94% |
|
|
MCE | HY-50673-10mg | 10mg | 现货 |
Dactolisib Dactolisi |
99.94% |
|
|
MCE | HY-50673-5mg | 5mg | 现货 |
Dactolisib Dactolisi |
99.94% |
|
|
MCE | HY-50673-1mg | 1mg | 现货 |
Dactolisib Dactolisi |
99.94% |
|
|